XML 23 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net income $ 48,747 $ 21,462 $ 63,903
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 13,756 14,164 14,592
Bad debt expense 620 310 554
Share-based compensation expenses 1,186 1,818 1,929
Loss (gain) on disposals of property and equipment 26 (2) (2)
Gain on disposals of equity method investment 0 (88) 0
Gain on disposals of investment in non-marketable equity securities, net 0 (1,682) (10,502)
Loss (gain) on disposals of marketable securities, net (10) (223) 31
Impairment loss on investment 0 0 309
Equity in losses of equity method investees 1,277 77 80
Valuation gain on financial instruments 0 0 (1,255)
Deferred income tax expense (benefit) (1,978) 4,148 3,816
Inventories write downs 23,342 9,785 8,198
Changes in:      
Accounts receivable (14,602) 41,656 (19,211)
Inventories (1,716) (15,054) 3,096
Prepaid expenses and other current assets (647) 2,067 1,053
Accounts payable 17,846 (54,905) 28,038
Accounts payable to related party 576 0 0
Income taxes payable 1,389 (6,475) 2,357
Other accrued expenses and other current liabilities (5,164) 5,987 (3,262)
Other liabilities 24 (516) (5)
Net cash provided by operating activities 84,672 22,529 93,719
Cash flows from investing activities:      
Purchases of property, plant and equipment (7,902) (9,982) (10,931)
Proceeds from disposals of property and equipment 9 8 1
Purchases of available-for-sale marketable securities (30,248) (63,051) (23,766)
Proceeds from disposals of available-for-sale marketable securities 38,532 46,720 22,021
Purchases of investment in non-marketable equity securities (1,600) 0 0
Proceeds from disposals of investment in non-marketable equity securities 0 1,682 19,691
Proceeds from capital reduction of investment 568 0 1,168
Purchase of equity method investment (37) (3,708) 0
Proceeds from disposals of equity method investment 0 179 0
Proceeds from (repayments of) refundable deposits, net 461 (304) (237)
Releases (pledges) of restricted marketable securities 240 (227) 2,697
Cash paid for loan made to related party (7,150) 0 0
Cash received from the acquisition of Liqxtal, net of cash paid of $1,780 0 341 0
Net cash provided by (used in) investing activities (7,127) (28,342) 10,644
Cash flows from financing activities:      
Payments of cash dividends (22,348) (51,364) (46,042)
Excess tax benefits from share-based compensation 0 771 1,232
Proceeds from disposals of subsidiary shares to noncontrolling interests by Himax Technologies Limited 0 0 83
Proceeds from disposals of subsidiary shares to noncontrolling interests by Himax Imaging, Inc. 9 22 38
Purchases of subsidiary shares from noncontrolling interests (376) (503) (1,515)
Releases (pledges) of restricted cash, cash equivalents and marketable securities (for borrowing of short-term debt) 42,000 (50,000) (24,500)
Proceeds from issuances of new shares by subsidiaries 0 1,466 0
Proceeds from short-term debt 230,000 412,303 417,500
Repayments of short-term debt (272,000) (362,303) (393,000)
Net cash used in financing activities (22,715) (49,608) (46,204)
Effect of foreign currency exchange rate changes on cash and cash equivalents (207) (216) (13)
Net increase (decrease) in cash and cash equivalents 54,623 (55,637) 58,146
Cash and cash equivalents at beginning of year 129,829 185,466 127,320
Cash and cash equivalents at end of year 184,452 129,829 185,466
Supplemental disclosures of cash flow information:      
Interest 637 516 592
Income taxes 11,534 12,505 13,311
Supplemental disclosures of investing activities affecting both cash and non-cash items:      
Purchase of property, plant and equipment 6,570 10,567 10,385
Decrease (increase) in payable for purchases of equipment and asset retirement obligations 1,332 (585) 546
Cash paid $ 7,902 $ 9,982 $ 10,931